-JENNIFER COUZIN

NOAA to Navy: Sssshhh
The U.S. Navy should turn down the volume of its proposed sonar training range, says the National Oceanic and Atmospheric Administration (NOAA), which publicly released its comments on the Navy's plans last week. The Navy wants to build a sonar training facility off the North Carolina coast, and last October it concluded that the sonar would not harm marine mammals. NOAA disagreed, citing the risk of driving beaked whales and other marine mammals onto beaches. Also, NOAA said, the endangered North Atlantic right whale has been sighted nearby. The Navy is now reviewing NOAA's concerns and more than 300 substantive public comments; the final report is expected in the fall.
-KATHERINE UNGER
Scripps Lands on Jupiter
Capping a two-and-a-half-year battle over siting, officials in Palm Beach County, Florida, voted last week to approve plans by the Scripps Research Institute to build an East Coast campus in Jupiter, Florida. A suit by environmentalists had prevented the San Diego, California-based research powerhouse from building on its original choice, a site near wetlands. So Scripps officials turned to the Abacoa campus of Florida Atlantic University, where more than 160 Scripps researchers are temporarily housed.
-ROBERT F. SERVICE SCIENCESCOPE PARIS-A French island in the Indian Ocean is reeling from an explosive outbreak of a littleknown viral disease. On 17 February, the French National Institute for Public Health Surveillance said that an estimated 110,000 residents of Réunion, population 770,000, had been infected with the chikungunya virus-almost 22,000 of them between 6 and 12 February alone. Chikungunya, which is spread by mosquitoes, is rarely fatal-of 52 patients who died, all but one were suffering from other diseases as well-but it can cause high fevers, rashes, and excruciating joint and muscle pains.
"It's a massive outbreak, it's absolutely alarming," says Stephen Higgs of the University of Texas Medical Branch in Galveston, one of a few dozen researchers around the world who study chikungunya, a member of the alphavirus genus that also includes rarities such as eastern equine encephalitis and western equine encephalitis. The epidemic has triggered a wave of activity in French labs to address scientific gaps; it could also breathe new life into a vaccine candidate developed by the U.S. Army that has been languishing for almost a decade.
Chikungunya-often shortened to "chik" by scientists-is a Swahili word that means "that which bends up," a reference to some victims' inability to walk upright. The disease is known to occur in large parts of Southeast and South Asia, as well as in Africa. Preliminary sequencing of virus isolates from Réunion at the Pasteur Institute in Lyon suggests that the virus was imported from East Africa, says Pasteur virologist Nathalie Pardigon. Other Indian Ocean islands-including Mauritius, the Seychelles, and the Comoroshave also have seen cases, although far fewer.
It's unclear why the outbreak is so ferocious. One factor, says virologist Charles Calisher of Colorado State University in Fort Collins, may be that the virus is hitting Réunion for the first time, so almost no one has resistance. The mosquito species implicated as the main culprit in Réunion-Aedes albopictus, also known as the Asian tiger mosquito-was not believed to be a very efficient chikungunya vector, says Pasteur entomologist Paul Reiter, because it bites many different species. But perhaps it has acquired a particular taste for humans in Réunion, he adds. A spokesperson for French health minister Xavier Bertrand confirms that the French government is in conversations with the U.S. health and defense departments. But much more work is needed on the vaccine, he cautions-for instance, to investigate side effects, such as joint pains, which developed in some vaccinees in the clinical trial.
To address the questions, the French government announced a broad research program last week, to be carried out by multiple institutes, and including basic virology, antiviral drugs and other treatments, vaccines, and mosquito ecology and control. On Monday, it also installed a panel to coordinate the battle, chaired by Antoine Flahault, head of the public health department at the Tenon Hospital in Paris.
